Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-30 @ 10:09 AM
Study NCT ID:
NCT06254560
Status:
RECRUITING
Last Update Posted:
2024-02-12
First Post:
2024-01-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
Sponsor:
Institute of Hematology & Blood Diseases Hospital, China
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-23
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-19
First Submit QC Date:
None
Study First Post Date:
2024-02-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-03
Last Update Post Date:
2024-02-12
Last Update Post Date Type:
ACTUAL